Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intervertebral Disc | 26 | 2011 | 114 | 1.790 |
Why?
|
| Bone Morphogenetic Proteins | 18 | 2009 | 64 | 1.180 |
Why?
|
| Proteoglycans | 20 | 2009 | 119 | 1.000 |
Why?
|
| Transforming Growth Factor beta | 10 | 2008 | 82 | 0.840 |
Why?
|
| Extracellular Matrix | 10 | 2009 | 48 | 0.800 |
Why?
|
| Cartilage, Articular | 9 | 2008 | 265 | 0.760 |
Why?
|
| Chondrocytes | 7 | 2009 | 97 | 0.600 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 43 | 0.430 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2008 | 10 | 0.380 |
Why?
|
| Animals | 26 | 2011 | 3272 | 0.320 |
Why?
|
| Hyaluronic Acid | 3 | 2006 | 33 | 0.310 |
Why?
|
| Interleukin-1 | 3 | 2008 | 48 | 0.300 |
Why?
|
| Cattle | 13 | 2009 | 112 | 0.290 |
Why?
|
| Neurosecretory Systems | 1 | 2008 | 3 | 0.290 |
Why?
|
| Cells, Cultured | 13 | 2009 | 472 | 0.280 |
Why?
|
| Bone Morphogenetic Protein 7 | 12 | 2008 | 28 | 0.270 |
Why?
|
| Spinal Diseases | 4 | 2011 | 107 | 0.260 |
Why?
|
| Intervertebral Disc Displacement | 5 | 2011 | 74 | 0.240 |
Why?
|
| Transduction, Genetic | 4 | 2009 | 15 | 0.230 |
Why?
|
| Lumbar Vertebrae | 3 | 2009 | 357 | 0.220 |
Why?
|
| Collagen | 8 | 2009 | 79 | 0.220 |
Why?
|
| Protective Agents | 1 | 2003 | 8 | 0.200 |
Why?
|
| Rabbits | 8 | 2008 | 167 | 0.190 |
Why?
|
| Wound Healing | 1 | 2003 | 113 | 0.190 |
Why?
|
| Keratan Sulfate | 5 | 2009 | 15 | 0.160 |
Why?
|
| Osteoarthritis | 4 | 2008 | 277 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2006 | 517 | 0.150 |
Why?
|
| Tissue Engineering | 3 | 2008 | 24 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2008 | 399 | 0.140 |
Why?
|
| High Mobility Group Proteins | 2 | 2007 | 3 | 0.130 |
Why?
|
| Synovial Fluid | 2 | 2008 | 82 | 0.130 |
Why?
|
| Chondroitin ABC Lyase | 2 | 2007 | 4 | 0.130 |
Why?
|
| Cell Transplantation | 3 | 2011 | 15 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2007 | 149 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2008 | 322 | 0.120 |
Why?
|
| Growth Substances | 2 | 2006 | 28 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2008 | 144 | 0.110 |
Why?
|
| Matrix Metalloproteinase 13 | 3 | 2008 | 19 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2008 | 250 | 0.110 |
Why?
|
| Cell Division | 4 | 2008 | 80 | 0.110 |
Why?
|
| Time Factors | 5 | 2008 | 1275 | 0.100 |
Why?
|
| Aggrecans | 3 | 2009 | 48 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2008 | 165 | 0.100 |
Why?
|
| Bone Regeneration | 2 | 2011 | 68 | 0.100 |
Why?
|
| RNA, Messenger | 4 | 2009 | 281 | 0.100 |
Why?
|
| DNA | 6 | 2009 | 95 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2007 | 152 | 0.090 |
Why?
|
| Proteins | 1 | 2011 | 53 | 0.090 |
Why?
|
| NF-kappa B | 2 | 2008 | 104 | 0.090 |
Why?
|
| Biological Products | 1 | 2011 | 31 | 0.090 |
Why?
|
| Cell Culture Techniques | 3 | 2006 | 30 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2011 | 83 | 0.080 |
Why?
|
| Intervertebral Disc Chemolysis | 2 | 2007 | 6 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2009 | 37 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2009 | 19 | 0.080 |
Why?
|
| Humans | 15 | 2011 | 23169 | 0.080 |
Why?
|
| Phytoestrogens | 1 | 2008 | 4 | 0.070 |
Why?
|
| Stilbenes | 1 | 2008 | 6 | 0.070 |
Why?
|
| Fruit | 1 | 2008 | 25 | 0.070 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 1 | 0.070 |
Why?
|
| raf Kinases | 1 | 2008 | 1 | 0.070 |
Why?
|
| Metabolism | 1 | 2008 | 5 | 0.070 |
Why?
|
| Substance P | 1 | 2008 | 10 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 29 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 18 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 38 | 0.070 |
Why?
|
| Adenoviridae | 4 | 2009 | 15 | 0.070 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2007 | 1 | 0.070 |
Why?
|
| Uniparental Disomy | 1 | 2007 | 1 | 0.070 |
Why?
|
| Sulfotransferases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 88 | 0.070 |
Why?
|
| Cell Survival | 4 | 2008 | 98 | 0.070 |
Why?
|
| Hindlimb | 2 | 2004 | 15 | 0.060 |
Why?
|
| Tendons | 1 | 2008 | 164 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2006 | 35 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 87 | 0.060 |
Why?
|
| Mutation | 1 | 2007 | 328 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2005 | 21 | 0.060 |
Why?
|
| Adult | 5 | 2009 | 7031 | 0.060 |
Why?
|
| Fibronectins | 1 | 2005 | 17 | 0.060 |
Why?
|
| Calcitonin | 1 | 2004 | 14 | 0.060 |
Why?
|
| Acetabulum | 1 | 2005 | 165 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 3 | 2009 | 14 | 0.050 |
Why?
|
| Genetic Vectors | 3 | 2008 | 55 | 0.050 |
Why?
|
| Chymopapain | 1 | 2003 | 5 | 0.050 |
Why?
|
| Viscosity | 1 | 2003 | 10 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2008 | 172 | 0.050 |
Why?
|
| Male | 7 | 2009 | 12556 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 56 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 131 | 0.050 |
Why?
|
| Hip Prosthesis | 2 | 2005 | 442 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1098 | 0.040 |
Why?
|
| Radiography | 3 | 2006 | 528 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2005 | 686 | 0.040 |
Why?
|
| Gene Expression | 2 | 2008 | 176 | 0.030 |
Why?
|
| Injections, Spinal | 2 | 2007 | 32 | 0.030 |
Why?
|
| Fibromodulin | 2 | 2009 | 3 | 0.030 |
Why?
|
| Decorin | 2 | 2009 | 5 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2009 | 8 | 0.030 |
Why?
|
| Biglycan | 2 | 2009 | 5 | 0.030 |
Why?
|
| Middle Aged | 5 | 2009 | 8000 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 131 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2008 | 87 | 0.030 |
Why?
|
| Dogs | 2 | 2005 | 146 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 3754 | 0.030 |
Why?
|
| Lectins, C-Type | 2 | 2004 | 51 | 0.030 |
Why?
|
| Prosthesis Design | 2 | 2005 | 390 | 0.020 |
Why?
|
| Female | 4 | 2009 | 13059 | 0.020 |
Why?
|
| Adolescent | 2 | 2007 | 1916 | 0.020 |
Why?
|
| Aged | 3 | 2009 | 7498 | 0.020 |
Why?
|
| Collagen Type X | 1 | 2009 | 3 | 0.020 |
Why?
|
| Lumican | 1 | 2009 | 2 | 0.020 |
Why?
|
| Vitis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2008 | 6 | 0.020 |
Why?
|
| DNA Replication | 1 | 2008 | 10 | 0.020 |
Why?
|
| ADAMTS4 Protein | 1 | 2008 | 15 | 0.020 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2008 | 12 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 31 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2008 | 37 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 29 | 0.020 |
Why?
|
| Homeostasis | 1 | 2008 | 65 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 98 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2008 | 3 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 256 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 12 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 28 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 26 | 0.020 |
Why?
|
| Back Pain | 1 | 2008 | 52 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 110 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 22 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 29 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 6 | 0.020 |
Why?
|
| Leucine | 1 | 2007 | 11 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 10 | 0.020 |
Why?
|
| Cornea | 1 | 2007 | 9 | 0.020 |
Why?
|
| Homozygote | 1 | 2007 | 13 | 0.020 |
Why?
|
| Pedigree | 1 | 2007 | 51 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2007 | 24 | 0.020 |
Why?
|
| Joints | 1 | 2008 | 67 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 149 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 115 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 166 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 246 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 210 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 5 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2006 | 6 | 0.020 |
Why?
|
| Autoantigens | 1 | 2006 | 15 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2006 | 11 | 0.020 |
Why?
|
| Swine | 1 | 2006 | 67 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 13 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2005 | 29 | 0.020 |
Why?
|
| Coccyx | 1 | 2005 | 1 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 167 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 65 | 0.010 |
Why?
|
| Porosity | 1 | 2005 | 55 | 0.010 |
Why?
|
| Hexuronic Acids | 1 | 2005 | 6 | 0.010 |
Why?
|
| Glucuronic Acid | 1 | 2005 | 6 | 0.010 |
Why?
|
| Alginates | 1 | 2005 | 7 | 0.010 |
Why?
|
| Chromium Alloys | 1 | 2005 | 30 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2005 | 18 | 0.010 |
Why?
|
| Tail | 1 | 2005 | 1 | 0.010 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2005 | 4 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 17 | 0.010 |
Why?
|
| Wounds, Stab | 1 | 2005 | 2 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 72 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 58 | 0.010 |
Why?
|
| Injections | 1 | 2005 | 42 | 0.010 |
Why?
|
| Arthrography | 1 | 2005 | 23 | 0.010 |
Why?
|
| Water | 1 | 2005 | 29 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2004 | 5 | 0.010 |
Why?
|
| Needles | 1 | 2005 | 17 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 134 | 0.010 |
Why?
|
| Biolistics | 1 | 2003 | 1 | 0.010 |
Why?
|
| Regeneration | 1 | 2003 | 14 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 2971 | 0.010 |
Why?
|
| Versicans | 1 | 2002 | 5 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 592 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 639 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 18 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2002 | 25 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 51 | 0.010 |
Why?
|
| Alloys | 1 | 2002 | 76 | 0.010 |
Why?
|
| Cobalt | 1 | 2002 | 76 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 811 | 0.010 |
Why?
|
| Low Back Pain | 1 | 2003 | 129 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2002 | 75 | 0.010 |
Why?
|
| Knee Joint | 1 | 2006 | 567 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1427 | 0.010 |
Why?
|
| Titanium | 1 | 2002 | 141 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2002 | 101 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 481 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 875 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 523 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 476 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 1512 | 0.010 |
Why?
|